Mirae Asset Global Etfs Holdings Ltd. Lyell Immunopharma, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 271,996 shares of LYEL stock, worth $247,516. This represents 0.0% of its overall portfolio holdings.
Number of Shares
271,996
Previous 312,406
12.94%
Holding current value
$247,516
Previous $452,000
17.04%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LYEL
# of Institutions
122Shares Held
142MCall Options Held
18.1KPut Options Held
200-
Mwg Management Ltd. Washington, DC20.2MShares$18.3 Million30.81% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$13.7 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$13.7 Million13.96% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$12.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$9.17 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $226M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...